[Postpartum Hemorrhage]. / Postpartale Hämorrhagie.
Anasthesiol Intensivmed Notfallmed Schmerzther
; 58(10): 583-597, 2023 Oct.
Article
em De
| MEDLINE
| ID: mdl-37832561
ABSTRACT
Postpartum hemorrhage (PPH) affects about 4% of all deliveries in high-income countries and continues to rise, a trend attributable to the increase in caesarean section rates and maternal morbidity. Preventive measures such as the precautionary administration of uterotonics effectively reduce the risk of severe bleeding irrespective of birth mode. As a time-critical condition and a significant contributor to adverse maternal outcomes, PPH needs to be diagnosed early by measuring, not estimating, blood losses. Institutional treatment algorithms should be available to guide stage-based interdisciplinary management without delay. The main therapy goals are to identify the etiology and stop the bleeding by using uterotonics and mechanical and surgical interventions, to restore hemodynamic stability by volume and transfusion therapy and to optimize hemostasis by laboratory- and viscoelastic assay-guided factor replacement. This review highlights current recommendations for prevention, diagnosis and treatment of PPH.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ocitócicos
/
Hemorragia Pós-Parto
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
De
Revista:
Anasthesiol Intensivmed Notfallmed Schmerzther
Assunto da revista:
ANESTESIOLOGIA
/
MEDICINA DE EMERGENCIA
/
TERAPIA INTENSIVA
Ano de publicação:
2023
Tipo de documento:
Article